首页> 外文期刊>Clinical and vaccine immunology: CVI >Role of CYP2E1 Immunoglobulin G4 Subclass Antibodies and Complement in Pathogenesis of Idiosyncratic Drug-Induced Hepatitis
【24h】

Role of CYP2E1 Immunoglobulin G4 Subclass Antibodies and Complement in Pathogenesis of Idiosyncratic Drug-Induced Hepatitis

机译:CYP2E1免疫球蛋白G4亚类抗体和补体在特异性药物诱发的肝炎发病中的作用

获取原文
       

摘要

Idiosyncratic drug-induced hepatitis (IDDIH) is the third most common cause for acute liver failure in the United States. Previous studies have attempted to identify susceptible patients or early stages of disease with various degrees of success. To determine if total serum immunoglobulin subclasses, CYP2E1-specific subclass autoantibodies, complement components, or immune complexes could distinguish persons with IDDIH from others exposed to drugs, we studied persons exposed to halogenated volatile anesthetics, which have been associated with IDDIH and CYP2E1 autoantibodies. We found that patients with anesthetic-induced IDDIH had significantly elevated levels of CYP2E1-specific immunoglobulin G4 (IgG4) autoantibodies, while anesthetic-exposed healthy persons had significantly elevated levels of CYP2E1-specific IgG1 autoantibodies. Anesthetic IDDIH patients had significantly lower levels of C4a, C3a, and C5a compared to anesthetic-exposed healthy persons. C1q- and C3d-containing immune complexes were significantly elevated in anesthetic-exposed persons. In conclusion, our data suggest that anesthetic-exposed persons develop CYP2E1-specific IgG1 autoantibodies which may form detectable circulating immune complexes subsequently cleared by classical pathway activation of the complement system. Persons susceptible to anesthetic-induced IDDIH develop CYP2E1-specific IgG4 autoantibodies which form small, nonprecipitating immune complexes that escape clearance because of their size or by direct inhibition of complement activation.
机译:异质性药物性肝炎(IDDIH)是美国急性肝衰竭的第三大最常见原因。先前的研究已尝试鉴定出各种程度的成功的易感患者或疾病的早期阶段。为确定总血清免疫球蛋白亚类,CYP2E1特异性亚类自身抗体,补体成分或免疫复合物是否能将IDDIH患者与其他药物暴露者区分开,我们研究了与IDDIH和CYP2E1自体抗体相关的卤化挥发性麻醉剂患者。我们发现麻醉剂诱导的IDDIH患者的CYP2E1特异性免疫球蛋白G4(IgG4)自身抗体水平显着升高,而麻醉剂暴露的健康人的CYP2E1特异性IgG1自身抗体水平显着升高。与麻醉剂暴露的健康人相比,麻醉剂IDDIH患者的C4a,C3a和C5a水平显着降低。麻醉暴露者中含C1q和C3d的免疫复合物显着升高。总之,我们的数据表明,麻醉药暴露的人会产生CYP2E1特异性IgG1自身抗体,这些抗体可能形成可检测的循环免疫复合物,随后通过补体系统的经典途径激活而被清除。易受麻醉剂诱导的IDDIH感染的人会产生CYP2E1特异性IgG4自身抗体,这些抗体会形成小的,无沉淀的免疫复合物,由于其大小或通过直接抑制补体激活而无法清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号